Activated immune-inflammatory pathways are associated with long-standing depressive symptoms: Evidence from gene-set enrichment analyses in the Young Finns Study

Journal of Psychiatric Research

Volumn 71, Issue , 2015, Pages 120-125

  Elovainio, Marko ^a,b   Taipale, Tuukka ^c   Seppälä, Ilkka ^c   Mononen, Nina ^c   Raitoharju, Emma ^c   Jokela, Markus ^a   Pulkki Råback, Laura ^a   Illig, Thomas ^d,e   Waldenberger, Melanie ^d   Hakulinen, Christian ^a   Hintsa, Taina ^a   Kivimäki, Mika ^f,g   Kähönen, Mika ^h   Keltikangas Järvinen, Liisa ^a   Raitakari, Olli ^i,j   Lehtimäki, Terho ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁱ UNIVERSITY OF TURKU   (Finland)

^j UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Gene expression depression; Gene set pathways; Gene set enrichment analyses

Indexed keywords

B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; NEF PROTEIN; PROTEIN KINASE B; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CLINICAL TRIAL; DEPRESSIVE DISORDER; FINLAND; GENE EXPRESSION PROFILING; IMMUNOLOGY; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX;

ADULT; DEPRESSIVE DISORDER; FEMALE; FINLAND; GENE EXPRESSION PROFILING; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84945975501     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.09.017     Document Type: Article

References (40)

1. Anitha A., Nakamura K., Yamada K., Iwayama Y., Toyota T., Takei N., et al. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder. Biol. Psychiatry 2008, 63(7):678-685.
2. Barbosa I.G., et al. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients. J. Psychiatr. Res. 2013, 47:1949-1954.
3. Brummet B., Boyle S., Ortel T., Becker R., Siegler I., Williams R. Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosom. Med. 2010, 72:333-339.
4. Carlin J.M., Ozaki Y., Byrne G.I., Brown R.R., Borden E.C. Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 1989, 45(6):535-541.
5. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38(2):157-160.
6. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
7. Elovainio M., Keltikangas-Jarvinen L., Kivimaki M., Pulkki L., Puttonen S., Heponiemi T., et al. Depressive symptoms and carotid artery intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Psychosom. Med. 2005, 67(4):561-567.
8. Elovainio M., Keltikangas-Jarvinen L., Pulkki-Raback L., Kivimaki M., Puttonen S., Viikari L., et al. Depressive symptoms and C-reactive protein: the cardiovascular risk in Young Finns study. Psychol. Med. 2006, 36(6):797-805.
9. Elovainio M., Keltikangas-Järvinen L., Pulkki-Råback L., Kivimäki M., Puttonen S., Viikari L., et al. Depressive symptoms and C-reactive protein: the cardiovascular risk in Young Finns Study. Psychol. Med. 2006, 36:797-805.
10. Elovainio M., Aalto A.M., Kivimaki M., Pirkola S., Sundvall J., Lonnqvist J., et al. Depression and C-reactive protein: population-based health 2000 study. Psychosom. Med. 2009, 71(4):423-430.
11. Elovainio M., Hurme M., Jokela M., Pulkki-Råback L., Kivimäki M., Hintsanen M., et al. Indoleamine 2,3-dioxygenase (IDO) activation and depressive symptoms; results from the Young Finns study. Psychosom. Med. 2012, 74:675-681.
12. Ford D.E., Erlinger T.P. Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Archives Intern. Med. 2004, 164(9):1010-1014.
13. Hobara T., Uchida S., Otsuki K., Matsubara T., Funato H., Matsuo K., et al. Altered gene expression of histone deacetylases in mood disorder patients. J. Psychiatr. Res. 2010, 44(5):263-270.
14. Hung Y.Y., Kang H.Y., Huang K.W., Huang T.L. Association between toll-like receptors expression and major depressive disorder. Psychiatry Res. 2014, 220:283-286.
15. Judd L.L., Schettler P.J., Akiskal H.S. The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr. Clin. North Am. 2002, 25(4):685-698.
16. Katainen S., Räikkönen K., Keltikangas-Järvinen L. Adolescent temperament, perceived social support, and depressive tendencies as predictors of depressive tendencies in young adulthod. Eur. J. Personal. 1999, 13:183-207.
17. Kivimäki M., Shipley M.J., Batty G.D., Hamer M., Akbaraly T.N., Kumari M., et al. Long-term inflammation increases risk of common mental disorder: a cohort study. Mol. Psychiatry 2014, 19:149-150.
18. Leonard B.E., Myint A. The psychoneuroimmunology of depression. Hum. Psychopharmacol. 2009, 24(3):165-175.
19. Levula M., Oksala N., Airla N., Zeitlin R., Salenius J.-P., et al. Genes involved in systemic and arterial bed dependent atherosclerosis - tampere vascular study. PloS One 2012, 7(4):e33787. 10.1371/journal.pone.0033787.
20. Lönnqvist J. Stressi ja depressio. Duodecim 2009, 5:3.
21. Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 1999, 461:25-46.
22. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:664-675.
23. Petersen A.C., Compas B.E., Brooks-Gunn J., Stemmler M., Ey S., Grant K.E. Depression in adolescence. Am. Psychol. 1993, 48(2):155-168.
24. Pulkki-Råback L., Elovainio M., Hakulinen C., Lipsanen J., Hintsanen M., Jokela M., et al. Cumulative effect of psychosocial factors in youth on ideal cardiovascular health in adulthood. The cardiovascular risk in Young Finns Study. Circulation 2015, 131:245-253.
25. Raison, C.L., Miller, A.H. The evolutionary significance of depression in pathogen host defense (PATHOS-D). Mol. Psychiatry, 18: 15-37.
26. Raitakari O.T., Juonala M., Rönnemaa T., Keltikangas-Järvinen L., Räsänen L., Pietikäinen M., et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int. J. Epidemiol. 2008, 1-7.
27. Rege S., Hodgkinson S.J. Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application. Aust. N. Z. J. Psychiatry 2013, 47:136-151.
28. Rosenström T., Jokela M., Puttonen S., Hintsanen M., Pulkki-Råback L., Viikari J.S., et al. Pairwise measures of causal direction in the epidemiology of sleep problems and depression. PLoS One 2012, 7:e50841.
29. Salmela-Aro K., Nurmi J.-E. Depressive symptoms and personal project appraisals: a cross-lagged longitudinal study. Personal. Individ. Differ. 1996, 21:373-381.
30. Schurmann C., Heim K., Schillert A., Blankenberg S., Carstensen M., Dörr M., et al. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the MetaXpress consortium. PLoS One 2012, 7:e50938.
31. Shi Y., Oshlack M., Smyth J. Optimizing the noise versus bias trade-off for illumina whole genome expression BeadChips. Nucleic Acids Res. 2010, 38:e204.
32. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
33. Subramanian A., Kuehn H., Gould J., Tamayo P., Mesirov J.P. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 2007, 23(23):3251-3253.
34. Telama R., Yang X., Laakso L., Viikari J. Physical activity in childhood and adolescence as predictor of physical activity in young adulthood. Am. J. Prev. Med. 1997, 13(4):317-323.
35. Uher R., Tansey K., Dew T., Maier W., Mors O., Hauser J., et al. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am. J. Psychiatry 2014, 171:1278-1366.
36. Vialou V., Feng J., Robison A.J., Nestler E.J. Epigenetic mechanisms of depression and antidepressant action. Annu. Rev. Pharmacol. Toxicol. 2013, 53:59-87.
37. Whiteford H.A., Degenhardt L., R J., Baxter A.J., F A.J., Erskine H.E., et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 2013, 382:1575-1586.
38. Whiteford H.A., Degenhardt L., Rehm J., Baxter A., Ferrari A., Erskine H.E., et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 2013, 382:1575-1586.
39. Witt S.H., Juraeva D., Sticht C., Strohmaier J., Meier S., Treutlein J., et al. Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder. Transl. Psychiatry 2014, 4:e426.
40. Yu H.N., et al. Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Arch. Med. Res. 2014, 45:195-200.